MedSci Healthcare Holdings Limited (HKG:2415)
0.9700
-0.0100 (-1.02%)
Jun 18, 2026, 11:45 AM HKT
HKG:2415 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 17.94 | 24.97 | 55.04 | -99.88 | -151.03 |
Depreciation & Amortization | 5.32 | 6.52 | 7.7 | 8.3 | 8.48 |
Other Amortization | 0.31 | 0.67 | 0.65 | 0.08 | - |
Loss (Gain) From Sale of Assets | - | - | - | 0.07 | -0.84 |
Loss (Gain) From Sale of Investments | 5.01 | -23.41 | -6.97 | - | - |
Stock-Based Compensation | 3.46 | 19.06 | 5.37 | 6.27 | 8.15 |
Provision & Write-off of Bad Debts | 13.42 | 14.02 | 13.6 | 2.54 | 6.42 |
Other Operating Activities | 1.42 | -4.59 | -10.29 | 103.74 | 197.57 |
Change in Accounts Receivable | -22.34 | 8.23 | -34.35 | -24.55 | -47.43 |
Change in Accounts Payable | 1.59 | -0.02 | 0.09 | 0.38 | -0.8 |
Change in Other Net Operating Assets | -24.11 | 9.36 | 7.21 | -10.99 | 16.83 |
Operating Cash Flow | 2.02 | 54.81 | 38.04 | -14.04 | 37.35 |
Operating Cash Flow Growth | -96.31% | 44.11% | - | - | -33.54% |
Capital Expenditures | -0.03 | -0.2 | -0.18 | -0.52 | -0.89 |
Sale of Property, Plant & Equipment | - | 0.02 | - | 0.03 | - |
Divestitures | - | - | - | - | -1.15 |
Sale (Purchase) of Intangibles | - | -0.14 | -1.77 | -1.65 | - |
Investment in Securities | 12.59 | -313.04 | -493.27 | - | - |
Other Investing Activities | 0.5 | -3.33 | 0.25 | - | - |
Investing Cash Flow | 13.05 | -316.7 | -494.97 | -2.13 | -2.03 |
Long-Term Debt Repaid | -4.23 | -5.44 | -6.92 | -7.62 | -7.67 |
Net Debt Issued (Repaid) | -4.23 | -5.44 | -6.92 | -7.62 | -7.67 |
Issuance of Common Stock | - | 1.38 | 519.86 | - | - |
Repurchase of Common Stock | -0.37 | -0.37 | -42.01 | - | -3.88 |
Common Dividends Paid | -5.76 | - | - | - | - |
Other Financing Activities | - | - | - | 0.1 | - |
Financing Cash Flow | -10.35 | -4.42 | 470.93 | -7.52 | 285.56 |
Foreign Exchange Rate Adjustments | -3.93 | 4.66 | 15.33 | 26.96 | -1.84 |
Net Cash Flow | 0.79 | -261.65 | 29.32 | 3.26 | 319.03 |
Free Cash Flow | 1.99 | 54.61 | 37.86 | -14.56 | 36.46 |
Free Cash Flow Growth | -96.35% | 44.27% | - | - | -33.81% |
Free Cash Flow Margin | 0.74% | 20.95% | 10.84% | -4.17% | 12.25% |
Free Cash Flow Per Share | 0.00 | 0.10 | 0.07 | -0.03 | 4.26 |
Cash Income Tax Paid | 0.16 | 5.43 | 3.21 | 9.55 | -2.61 |
Levered Free Cash Flow | -14.06 | 39.63 | 19.48 | -25.05 | 19.17 |
Unlevered Free Cash Flow | -13.92 | 39.72 | 19.65 | -24.82 | 19.34 |
Change in Working Capital | -44.85 | 17.56 | -27.06 | -35.16 | -31.4 |